Abstract:Combinatorial biosynthesis with fungal polyketide synthases (PKSs) promises to produce unprecedented bioactive "unnatural" natural products (uNPs) for drug discovery. Genome mining of the dothideomycete <i>Rhytidhysteron rufulum</i> uncovered a collaborating highly reducing PKS (hrPKS)–nonreducing PKS (nrPKS) pair. These enzymes produce trace amounts of rare S-type benzenediol macrolactone congeners with a phenylacetate core in a heterologous host. However, subunit shuffling and domain swaps with voucher enzymes demonstrated that all PKS domains are highly productive. This contradiction led us to reveal novel programming layers exerted by the starter unit acyltransferase (SAT) and the thioesterase (TE) domains on the PKS system. First, macrocyclic vs linear product formation is dictated by the intrinsic biosynthetic program of the TE domain. Next, the chain length of the hrPKS product is strongly influenced <i>in trans</i> by the off-loading preferences of the nrPKS SAT domain. Last, TE domains are size-selective filters that facilitate or obstruct product formation from certain priming units. Thus, the intrinsic programs of the SAT and TE domains are both part of the extrinsic program of the hrPKS subunit and modulate the observable metaprogram of the whole PKS system. Reconstruction of SAT and TE phylogenies suggests that these domains travel different evolutionary trajectories, with the resulting divergence creating potential conflicts in the PKS metaprogram. Such conflicts often emerge in chimeric PKSs created by combinatorial biosynthesis, reducing biosynthetic efficiency or even incapacitating the system. Understanding the points of failure for such engineered biocatalysts is pivotal to advance the biosynthetic production of uNPs.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/jacs.0c07050?goto=supporting-info">https://pubs.acs.org/doi/10.1021/jacs.0c07050</a>.Experimental and bioinformatic procedures, descriptions on the isolation and structure elucidation of compounds, spectroscopic data, supplementary figures including additional structures, product distributions during combinatorial biosynthesis, and phylogenetic trees (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c07050/suppl_file/ja0c07050_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Fine-tuning of proteasome inhibitors through rational pathway engineering

Bioengineering of syrbactin megasynthetases for immunoproteasome inhibitor production

Protein engineering for natural product biosynthesis and synthetic biology applications

Evolution-inspired engineering of nonribosomal peptide synthetases

Combinatorial Pathway Optimization in Escherichia Coli by Directed Co‐evolution of Rate‐limiting Enzymes and Modular Pathway Engineering

Biosynth Pipeline: An integrated platform for merging the computational design of chimeric type I polyketide synthases with enzymatic pathways for chemical biosynthesis

Narrowing the gap between the promise and reality of polyketide synthases as a synthetic biology platform

Evolution-guided engineering of trans -acyltransferase polyketide synthases

Reshaping the 2‐pyrone Synthase Active Site for Chemoselective Biosynthesis of Polyketides

Re‐Engineering Fungal Nonribosomal Peptide Synthetases by Module Dissection and Duplicated Thiolation Domains

Protein design for pathway engineering.

Targeted Genome Mining—From Compound Discovery to Biosynthetic Pathway Elucidation

Engineering from evolution

Tailoring Pathway Modularity in the Biosynthesis of Erythromycin Analogs Heterologously Engineered in E. Coli

Intrinsic and Extrinsic Programming of Product Chain Length and Release Mode in Fungal Collaborating Iterative Polyketide Synthases

Recent advances in the heterologous expression of microbial natural product biosynthetic pathways

Engineering Biosynthesis of Non-ribosomal Peptides and Polyketides by Directed Evolution

Structure-driven protein engineering for production of valuable natural products

Dedicated Ent-Kaurene and Ent-Atiserene Synthases for Platensimycin and Platencin Biosynthesis

Synbiological Systems for Complex Natural Products Biosynthesis

Maximizing Heterologous Expression of Engineered Type I Polyketide Synthases: Investigating Codon Optimization Strategies